DF
VCYT icon

Dunhill Financial’s Veracyte VCYT Stock Holding History

Dunhill Financial’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44 Hold
1
– – ﹤0.01% 1642
2025
Q4 		$58 Buy
+1
New +$40 ﹤0.01% 1609

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dunhill Financial's VCYT Position: Q1 2026 in Review

Dunhill Financial held its Veracyte (VCYT) position steady in Q1 2026 at 1 share worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #1642.

Dunhill Financial first reported a position in VCYT in Q4 2025 and has held it in 2 quarters since. The position peaked at $58 in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Dunhill Financial held 1 share of Veracyte worth $44 as of Q1 2026.
  • Dunhill Financial left its Veracyte share count unchanged in Q1 2026.
  • Veracyte made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #1642 holding.
  • Dunhill Financial first reported a position in Veracyte in Q4 2025 and has held it in 2 quarters since.
  • Dunhill Financial's Veracyte position peaked at $58 in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.